News | Advanced Visualization | October 30, 2015

Oxford Imaging Technology Promises Earlier Tumor Diagnosis

Startup company to introduce ultrasound technology that provides MRI-quality imaging for enhanced tumor detection

October 30, 2015 — A spinout from Oxford’s Department of Engineering Science has raised £1 million from a high net worth Chinese investor to develop an imaging technology which could help doctors detect cancers, particularly prostate and liver tumors. Early diagnosis of cancer has been shown to save lives, and the Oxford technology will allow for improved visualization of tumors for earlier detection.

The company, Oxford Enhanced Medical Limited (OxEML), has been set up with support from Isis Innovation, the university’s commercialization company, based on technology invented by Prof. David Edwards and Prof. Chris Stevens. The investor, Mr. Zhang, was a VP of Hisun-Pfizer Pharma, China. He played a key role in building the company to over 2,500 employees and revenues of $850M USD.

Edwards said: “At the moment many doctors have limited access to expensive MRI [magnetic resonance imaging] diagnostic technology. Our approach would enable them to potentially identify and therefore treat common cancers earlier by bringing a new imaging and tissue characterization technique to clinicians. Our aim with the OxEML technology is to improve patient care by providing clinicians with MRI-like information using more accessible, cheaper enhanced ultrasound instruments. This will allow earlier, cost-effective diagnosis, particularly for patients in remote areas without easy access to MRI services.

“The OxEML system uses electromagnetic and acoustic waves to create a new class of medical images at a cost comparable to ultrasound. For doctors, the enhanced images contain new information, which should enable clinicians to more easily distinguish between normal and cancerous tissue. We anticipate that this new technology will be considerably cheaper both in terms of capital cost and running costs compared with MRI,” said Edwards.

OxEML CEO Amol Karnick said: “The OxEML system can also be used by physicians to improve biopsy targeting, making testing and treatment shorter and more effective, and to monitor patients to determine whether treatment is working.”

OxEML will continue to work with its existing partner, Canada’s Centre for Imaging Technology Commercialization, to develop and test its ultrasound imaging technology.

OxEML holds patents which have been granted in several territories including the United States, China and Japan.

For more information: www.isis-innovation.com

Related Content

iSchemaView Brings RAPID Imaging Platform to Australia and New Zealand
News | Stroke | July 13, 2018
iSchemaView has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAPID cerebrovascular...
Siemens Healthineers Launches Acuson Sequoia Ultrasound
Technology | Ultrasound Imaging | July 12, 2018
July 12, 2018 — Siemens Healthineers recently announced the launch of its new ultrasound system, the Acuson Sequoia.
EchoNous Vein Receives FDA Approval to Improve First-Time Peripheral IV Catheter Insertion
Technology | Ultrasound Imaging | July 12, 2018
EchoNous has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the EchoNous Vein, an ultrasound-...
Hologic Announces Availability of Viera Portable Breast Ultrasound System
Technology | Ultrasound Women's Health | July 11, 2018
Hologic’s new Viera portable breast ultrasound system is now available for purchase in the United States and Europe....
Healcerion Receives FDA Approval for Sonon 300L Handheld Ultrasound Device
Technology | Ultrasound Imaging | July 09, 2018
South Korea-based Healcerion launched the Sonon 300L wireless handheld ultrasound device to the U.S. market following U...
High-Strength MRI May Release Mercury from Amalgam Dental Fillings
News | Magnetic Resonance Imaging (MRI) | July 05, 2018
Exposure to ultra-high-strength magnetic resonance imaging (MRI) may release toxic mercury from amalgam fillings in...
Neural Analytics Inc. Receives CE Mark for Robotic Ultrasound System
Technology | Ultrasound Imaging | July 03, 2018
Medical robotics company Neural Analytics Inc. announced that it received CE Mark for its NeuralBot System, a robotic...
Ensuring that the FMDS for MRI safety is mounted outside Zone IV provides maximum early warning.

Ensuring that the FMDS for MRI safety is mounted outside Zone IV provides maximum early warning. (Images courtesy of Metrasens)

Feature | Magnetic Resonance Imaging (MRI) | July 03, 2018 | By Tobias Gilk
Nearly every job in the country is subject to certain health and safety regulations. Construction workers must wear...
3-D Imaging and Computer Modeling Capture Breast Duct Development

An image of a developing mammary duct. Image courtesy of Andrew Ewald.

News | Breast Imaging | June 28, 2018
A team of biologists has joined up with civil engineers to create what is believed to be the first 3-D computer model...
Konica Minolta Launches SonImage MX1 Portable Ultrasound System
Technology | Ultrasound Imaging | June 28, 2018
Konica Minolta Healthcare Americas Inc. introduced the SonImage MX1 portable ultrasound system, optimized for...
Overlay Init